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AVIAN TUBERCULOSIS IN A WHOOPING CRANE: TREATMENT AND OUTCOME 
S. BRET SNYDER, Albuquerque Biological Park, Rio Grande Zoo, 903 10th Street S.W., Albuquerque, NM 87102, USA 
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Abstract: A whooping crane (Grns americana) confirmed as suffering from Mycobacterium avium infection was treated for 1 year 
with daily doses of rifampin (45 mg/kg) and ethambutol (30 mg/kg) and 2 doses of M. vaccae antigen. Remission of disease occurred 
during therapy; however, recrudescence to active infection was suspected by 10 months after the antitubercular drugs were 
discontinued when the crane exhibited weight loss and had thickening of bowel wall as seen on radiographs. A second therapeutic 
regimen using azithromycin was then initiated (40 mg/kg fed daily) and was accompanied by a second remission within 6 weeks. After 
16 weeks of azlthromycin therapy, ethambutol (30 mg/kg daily) was added to the azithromycin to reduce the probability of emergent 
drug resistance. Three weeks later the crane developed severe hepatic dysfunction as suggested by blood chemistry values. This 
contributed to the crane's collapse and eventual death. All tissues cultured were negative for M. avium infection. A severe hepatopathy 
and chronic fibrosing cardiomyopathy may have resulted from the drug combinations. This case suggests azithromycin as a promising 
therapeutic agent in treatment of avian tuberculosis and warrants further investigation. 
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Treatment of avian tuberculosis is seldom attempted 
because of the long time interval for assessing outcome of 
treatment and the potential for suppression of disease rather 
than cure. This may result in recrudescence, further· 
transmission of infection, and increased zoonotic exposure 
(Bush et a1. 1978, Farer 1978, Beehler 1990). However, 
endangered species or otherwise valuable birds may justify 
special consideration. Recent reports suggest treatment can be 
successful in some cases of avian mycobacteriosis (Rosskopf 
and Woerpel 1991, VanDerHeyden 1994) although these 
diagnoses were not confirmed as M. avium infection by 
bacterial isolation. Drugs used in treatment of psittacine 
species were various combinations of isoniazid, rifampin, 
ethambutol, streptomycin, clofazimine, and cyclocerine. This 
report follows the course of treatment and outcome over 29 
months of a whooping crane infected in the wild with M. 
avium. 
We thank 1. P. Thilsted, New Mexico Veterinary 
Diagnostic Services (NMVDS), New Mexico Department of 
Agriculture, for biopsy histopathology and R. B. Ferguson, 
Tuberculosis and Mycology Section, Scientific Laboratory 
Division, New Mexico Department of Health, for isolation 
and identification of M. avium complex. D. G. Teubert, 
Senior Research Specialist, Department of Pathobiological 
Sciences, School of Veterinary Medicine, University of 
Wisconsin- Madison, verified the isolate as M. avium by 
DNA probe. R. L. Cromie, The Wildfowl and Wetlands 
Trust, United Kingdom, provided M. vaccae antigen, and S. 
B. Kadin and D. 1. Williams, Pfizer Laboratories, Inc., 
Groton, Comlecticut, donated azithromycin. Helpful com-
ments were given by 1. C. Lewis, U.S, Fish and Wildlife 
Service (USFWS), and by other reviewers of the manuscript. 
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CASE REPORT 
A debilitated 5-year-old male whooping crane from the 
experimental Rocky Mountain flock (Drewien and Bizeau 
1978) was captured at the Monte Vista National Wildlife 
Refuge, Colorado, and transported to the Rio Grande Zoo, 
Albuquerque, New Mexico, on 5 November 1992 by 
University of Idaho biologists. Details of the initial case 
presentation, diagnostic workup, and patient management 
have been reported (Snyder and Richard 1994). At initial 
examination the bird was thin (weight 5.78 kg) and had a 
large, easily palpable, mid-coelomic mass and a chronic 
cloacal prolapse. A firm 2-cm tissue mass was palpable 
within the prolapsed tissue. 
Initial diagnostic tests included blood samples for 
hematology and serum biochemistry, feces for ova and 
parasites, whole body radiographs, and biopsy and culture of 
the tissue mass in the wall of the prolapsed cloaca. Radio-
graphs and biopsy were done under isoflurane anesthesia. 
The prolapse was reduced and held in place with a purse-
string suture. 
Radiographs confirmed a large, mid-coelomic soft tissue 
density and splenomegaly. The initial white blood cell count 
(WBe) was estimated to be elevated (8-10 WBC/oil immer-
sion field). Dissection of the cloacal mass revealed pockets 
of brownish, inspissated exudate within a firm fibrous-like 
stroma. Histologically, there were numerous coalescing 
granulomas with necrotic centers surrounded by zones of 
macrophages. An acid fast strain showed rod-shaped, acid-
fast bacteria in the centers of many of the granulomas. The 
preliminary diagnosis was avian tuberculosis, and a decision 
was made to attempt treatment based on reports of success in 
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some psittacine species (Rosskopf and Woerpel 1991, 
VanDerHeyden 1994). Mycobacteriosis or other granuloma-
tous diseases were differential diagnoses. M. avium complex 
was confirmed in 3 weeks by isolation from the biopsy tissue 
(organism on file, NMVDS). The isolate was later verified 
as M. avium by use of a specific DNA probe for this organ-
ism. 
First Treatment Regimen 
Antitubercular treatment was initiated on 12 November 
1992 when the bird began to self feed, and was continued for 
1 year. Rifampin (Rifadin, Marion Merrell Dow, Inc.) and 
ethambutol (Myambutol, Ledede) were started at 30 mg/kg 
daily. The measured portion of powder and tablet were 
loaded into gelatin capsules and placed into the body cavity 
of a mouse or herring, which the bird ate. The dosage of 
rifampin was increased to 45 mg/kg daily (on 10 December 
1992) for the remainder of the treatment year. Isoniazid 
(Isoniazid, USP, Rugby Laboratories) was unsuccessfully· 
added as a third antitubercular drug at a dose of 30 mg/kg 
daily on 2 occasions early in treatment. On both attempts the 
bird became anorectic within 3 days but resumed eating when 
isoniazid was discontinued. 
The purse-string suture at the cloaca was removed in 
mid-January when pericloacal swelling had regressed 
sufficiently. M. vaccae antigen (Cromie 1991) was started at 
that time. Two O.05-mt doses of the vaccine were given 
intradermally 8 weeks apart in the thick skin on top of the 
head. 
Monitoring of the patient throughout treatment was by 
physical examinations, radiography, hematology, serum 
biochemistry, and feces collection for demonstration of acid-
fast bacilli by staining and by mycobacterial culturing. These 
data were collected at various intervals from monthly to 
quarterly throughout treatment. The mid-coelomic mass and 
spleen were markedly reduced in size by 9 March 1993, 4 
months after treatment with antitubercular drugs was begun. 
At this time the cloacal mass was palpable at less than I cm. 
Nine months after treatment was started (6 August 1993), all 
tests were within normal parameters, including radiographs. 
The cloacal mass was no longer palpable. The WBC (by 
eosinophil Unopette method) had decreased from 32,787/,u1 
on 16 December 1992 to 6,2061,u1 on 6 August 1993. 
The bird continued to appear normal on 10 June 1994, 6 
months after administration of antitubercular drugs was 
discontinued, although it had experienced a weight loss of 
0.22 kg from 25 February 1994. This weight loss was 
possibly an early manifestation of recrudescence. Sequential 
blood values during treatment and observation have been 
reported (Snyder and Richard 1994). 
Second Treatment Regimen 
By 15 September 1994 there was additional weight loss 
of 0.28 kg and an increase in the WBC from 10,304/,u1 in 
June 1994 to 20,2801,u1. Radiographs taken 23 September 
1994 showed prominent loops of intestine in the pelvic 
region which were interpreted as uniform thickened bowel 
wall. No other abnormal findings were evident; the bird's 
appetite was normal and fecal cultures were negative for 
mycobacteria. 
Although M. avium was not again isolated from the bird 
by fecal culture, we considered recrudescence of infection as 
the cause of the recurrent wasting illness and bowel wall 
thickening. Treatment with azithromycin (Pfizer Laborato-
ries, Inc.) was initiated 26 October 1994 at 20 mg/kg given 
in food daily. After 1 week the dose was increased to 40 
mg/kg and was continued 16 weeks unti115 February 1995 
with no ill effect. We decided to initially give azithromycin 
alone to test its potential usefulness in treatment. The bird 
made a dramatic improvement~ weight gain was 0.57 kg over 
the first 6 weeks on azithromycin (26 October to 8 December 
1994) and the WBC dropped to < 10,000/ ,ul. The bird again 
appeared in full remission. 
Third Treatment Regimen 
The drug manufacturer recommended using azithromycin 
in combination with other antibiotics to reduce the probabil-
ity of emergence of drug resistant M. avium. Thus, after 16 
weeks of azithromycin therapy, a second antibiotic, etham-
butol (30 mg/kg daily), was added (starting 15 February 
1995). After 3 weeks of treatment with this combination (8 
March 1995), the bird was found collapsed and unable to 
stand; both antibiotics were discontinued. Body weight had 
dropped 1.5 kg (to 4.69 kg), WBC was 10,442/,u1, and 
serum aspartate aminotransferase (AST) was> 760 mg/dl. 
The serum AST had been 310 mg/dl in June 1994 and 321 
mg/dl in September 1994. Tube feeding and intensive 
supportive care were initiated and continued for 3 weeks as 
the bird' s condition worsened until euthanasia was performed 
on 4 April 1995. The carcass was submitted to National 
Wildlife Health Center, Madison, Wisconsin, for complete 
necropsy. 
Feces were collected for acid-fast bacilli (AFB) stain and 
mycobacterial culture on 17 occasions between 12 November 
1992 and 10 March 1995 (29 months). AFB stains were 
negative on all samples. Cultures were negative for mycobac-
teria in 9 of the samples; M. Jortuitum was isolated from 1 
sample (28 January 1994), M. terrae was isolated from 2 
samples (23 August 1994 and 23 November 1994), and 5 
samples were overgrown by contaminant bacteria. 
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Necropsy Findings 
A complete necropsy was performed including gross and 
histopathology, virology, parasitology, bacteriology, and TB 
culture. Gross necropsy revealed significant lesions involving 
the heart and liver. There was serosanguinous fluid within the 
pericardial sac, a mildly cloudy pericardium, and a pale area 
on the left ventricular wall. The liver was large with rounded 
borders and was orange/red and mottled. Bile was red-tinged 
and watery. There was no evidence of the coelomic or 
cloacal masses found at initial presentation and no tubercular-
type lesions were seen in the gastrointestinal tract, liver, or 
spleen. Histologic lesions were a severe chronic active 
fibrosing cardiomyopathy and a severe hepatopathy that was 
suggestive of a toxic reaction. Acid-fast stains failed to reveal 
evidence of acid-fast bacteria, and no mycobacteria were 
recovered from cultures of spleen, liver, and ceca. 
DISCUSSION 
Avian tuberculosis, confirmed by isolation of M. avium 
from granulomatous tissue, was resolved in this whooping 
crane before its death from an apparent adverse drug reaction 
(azithromycin + ethambutol). The first drug regimen 
(rifampin + ethambutol + M. vacca e) induced remission of 
disease, but 10 months after the antitubercular drugs were 
discontinued, the recurrence of wasting illness suggested 
recrudescence of infection. Treatment with azithromycin 
brought about a rapid and pronounced second remission. It is 
unknown if the final combination (azithromycin + ethambu-
tol) contributed to the control of infection or if the apparent 
cure had already been effected. Although the results of 
necropsy suggest that mycobacterial infection was resolved, 
a sufficient time interval to assess the long-term outcome was 
not possible. 
Azithromycin, a macrolide antibiotic, has shown in vitro 
and in vivo activity against M. avium complex infection in 
persons with AIDS (Young et a1. 1991, Cynamon and 
Klemens 1994). The results of this clinical trial suggest 
further investigation of azithromycin as a promising therapeu-
tic agent for M. avium infection in birds. 
The etiology of the hepatopathy and cardiomyopathy found 
at necropsy cannot be proven, but the toxic nature of the 
changes and their temporal relationship to drug therapy 
(azithromycin + ethambutol) suggest an adverse reaction to 
the drugs. A recent report describes fulminant hepatic failure 
in humans undergoing antitubercular therapy with rifampin 
and/or isoniazid (Mitchell et al. 1995). A similar event likely 
occurred in this bird when given azithromycin and ethambutol. 
Fecal AFB strains and cultures were not reliable for 
either diagnosis or surveillance of infection in this whooping 
crane. These tests were negative before and during treatment 
as well as during recrudescence. Accurate diagnosis required 
biopsy of affected tissue. 
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